Skip to main content

Table 3 Multivariate logistic regression on risk of recurrence from 2011 to 2016 (n = 1362)

From: A clinical tool to predict Plasmodium vivax recurrence in Malaysia

Characteristic (reference) Beta Odds Ratio 95% CI P-value Score
Age (≥ 27 years)
 Less than 27 years 0.66 1.93 1.07 3.51 0.03 1
Gametocyte (<80 parasite/μL)
  ≥ 80 parasite/μL 1.53 4.60 1.06 19.84 0.04 2
Malaria transmission type (Non-indigenous)
 Indigenous 0.88 2.42 1.03 5.69 0.04 1
Treatment type (ACT plus PQ)
 CP plus PQ 0.96 2.61 0.78 8.74 0.12 2
Status of treatment (Complete)
 Incomplete 1.29 4.48 0.89 20.02 0.14 2
Total score       8
  1. ACT Artemisinin-based combination therapies, CP Chloroquine, PQ Primaquine